PT Kalbe Farma Tbk (FRA:LCLA) Cyclically Adjusted Book per Share: €0.02 (As of Mar. 2026)


FRA:LCLA PT Kalbe Farma Tbk FRA:LCLA
77 GF Score
Price €0.03
GF Value €0.07
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Kalbe Farma Tbk Cyclically Adjusted Book per Share?

PT Kalbe Farma Tbk FRA:LCLA 77 Cyclically Adjusted Book per Share is €0.02 as of Mar. 2026. GuruFocus rates FRA:LCLA with a GF Score™ of 77/100 and a GF Value™ of €0.07 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PT Kalbe Farma Tbk's adjusted book value per share for the three months ended in Mar. 2026 was €0.027. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.02 for the trailing ten years ended in Mar. 2026.

During the past 12 months, PT Kalbe Farma Tbk's average Cyclically Adjusted Book Growth Rate was 9.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 8.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of PT Kalbe Farma Tbk was 10.50% per year. The lowest was 8.60% per year. And the median was 9.95% per year.

As of today (2026-07-02), PT Kalbe Farma Tbk's current stock price is €0.03. PT Kalbe Farma Tbk's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €0.02. PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio of today is 1.50.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PT Kalbe Farma Tbk was 7.34. The lowest was 1.61. And the median was 5.24.


PT Kalbe Farma Tbk  (FRA:LCLA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.03/0.02
=1.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PT Kalbe Farma Tbk was 7.34. The lowest was 1.61. And the median was 5.24.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PT Kalbe Farma Tbk Cyclically Adjusted Book per Share Related Terms


PT Kalbe Farma Tbk Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for PT Kalbe Farma Tbk's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kalbe Farma Tbk Cyclically Adjusted Book per Share Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.01 0.02 0.02 0.01

PT Kalbe Farma Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.01 0.02

FRA:LCLA vs LLY, JNJ, ABBV: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Cyclically Adjusted PB Ratio falls into.


FRA:LCLA
77GF Score
PT Kalbe Farma Tbk FRA:LCLA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Kalbe Farma Tbk Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Kalbe Farma Tbk's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.027/136.5387*136.5387
=0.027

Current CPI (Mar. 2026) = 136.5387.

PT Kalbe Farma Tbk Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.015 103.212 0.020
201609 0.016 104.142 0.021
201612 0.018 105.222 0.023
201703 0.019 106.476 0.024
201706 0.017 107.722 0.022
201709 0.017 108.020 0.021
201712 0.018 109.017 0.023
201803 0.017 110.097 0.021
201806 0.017 111.085 0.021
201809 0.017 111.135 0.021
201812 0.019 112.430 0.023
201903 0.020 112.829 0.024
201906 0.019 114.730 0.023
201909 0.021 114.905 0.025
201912 0.022 115.486 0.026
202003 0.021 116.252 0.025
202006 0.022 116.630 0.026
202009 0.021 116.397 0.025
202012 0.022 117.318 0.026
202103 0.023 117.840 0.027
202106 0.022 118.184 0.025
202109 0.024 118.262 0.028
202112 0.026 119.516 0.030
202203 0.027 120.948 0.030
202206 0.026 123.322 0.029
202209 0.028 125.298 0.031
202212 0.027 126.098 0.029
202303 0.028 126.953 0.030
202306 0.027 127.663 0.029
202309 0.027 128.151 0.029
202312 0.027 129.395 0.028
202403 0.028 130.607 0.029
202406 0.027 130.792 0.028
202409 0.028 130.361 0.029
202412 0.030 131.432 0.031
202503 0.029 131.948 0.030
202506 0.026 133.241 0.027
202509 0.026 133.819 0.027
202512 0.026 135.271 0.026
202603 0.027 136.539 0.027

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.02 mean?
PT Kalbe Farma Tbk (FRA:LCLA) has a Cyclically Adjusted Book per Share of €0.02 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PT Kalbe Farma Tbk and its competitors.
Is PT Kalbe Farma Tbk's Cyclically Adjusted Book per Share too high?
PT Kalbe Farma Tbk's current Cyclically Adjusted Book per Share is €0.02. Overall, PT Kalbe Farma Tbk has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kalbe Farma Tbk's Cyclically Adjusted Book per Share compare to LLY and JNJ?
PT Kalbe Farma Tbk's Cyclically Adjusted Book per Share of €0.02 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PT Kalbe Farma Tbk and its competitors. PT Kalbe Farma Tbk's current Cyclically Adjusted Book per Share is €0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kalbe Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kalbe Farma Tbk (FRA:LCLA) is currently considered Significantly Undervalued. The stock's GF Value™ is €0.07, compared to a current price of €0.03 — trading 57.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is €0.02. PT Kalbe Farma Tbk's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For PT Kalbe Farma Tbk (FRA:LCLA), the current Cyclically Adjusted Book per Share is €0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kalbe Farma Tbk (FRA:LCLA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kalbe Farma Tbk stock appears to be undervalued. The current stock price of €0.03 is trading 57.1% below its estimated GF Value™ of €0.07. GuruFocus considers PT Kalbe Farma Tbk to be Significantly Undervalued.

Key valuation signals for FRA:LCLA:

  • Cyclically Adjusted Book per Share: €0.02
  • GF Value™: €0.07 vs. price of €0.03 (57.1% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the FRA:LCLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Kalbe Farma Tbk Business Description

Address Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, P.O. Box 3105, Jakarta, IDN, 10510
PT Kalbe Farma Tbk is engaged in the development, manufacturing, and trading of pharmaceutical products, including human medicines and consumer health products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. The majority of the company's revenue is derived from the distribution and logistics segments. Its Product and Services are Prescription /Ethicals, Consumer Health, Nutritionals, Distribution & Logistics, Health Services, Medical Devices, and Others.
77GF Score

Get the complete analysis for FRA:LCLA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.07
GF Value